A Brief Guide to Understanding: FDA's CMC Guidance for Phase 2 and 3 INDs
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
A Brief Guide to Understanding: FDA's CMC Guidance for Phase 2 and 3 INDs
-
Narrated by:
-
By:
About this listen
This audiocast discusses navigating CMC guidance, meeting regulatory requirements, drug substance/product information, FDA expectations, and quality requirements for progressing from Phase 2 to Phase 3.
No reviews yet